MATCHTX

MatchTx provides a SaaS solution that helps researchers, oncologists and clinical trial managers identify the full set of biomarkers that collectively predict the outcome of cancer patients to treatments. Patented algorithms classify millions of combinations of genomic and clinical data to find the full set predictive biomarkers (Deep Genetic Signatures™) from reference data sets. The Signatures are used to identify the previous tumors ‘most like my patient's cancer' to match therapeutics based on real patient outcomes, not just population averages... MatchTx has developed an automated, extensible, and assumption-free approach to predicting outcomes in cancer patients and matching patients to drugs/oncology clinical trials based on genomic, clinical, and outcomes data in cohorts. This approach was needed because whole genome sequencing and analysis has failed to identify general methods for translating sets of genetic variations into robust clinically actionable diagnostics. Because..

Also known as: MatchTx, LLC

Primary location: Columbus United States